2159103-66-7
2159103-66-7
Chemical Structure
Navocaftor
Synonym(s): GLPG 3067; ABBV-3067
- CAS No.: 2159103-66-7
- Formula:C15H11F3N4O5S
- Molecular Weight:416.33
IUPAC Name: (5-(3-amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)methanol
InChIKey: WOXOLLSAICIZNO-UHFFFAOYSA-N
SMILES: OCC1=NN=C(C2=NC=C(S(=O)(C3=CC=C(OC(F)(F)F)C=C3)=O)C=C2N)O1
Biological Activity: Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Navocaftor | 99.20% | Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Navocaftor (Standard) | ≥98% | Navocaftor (Standard) is the analytical standard of Navocaftor (HY-109152). This product is intended for research and analytical applications. Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
